1. Home
  2. ALXO vs GWH Comparison

ALXO vs GWH Comparison

Compare ALXO & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • GWH
  • Stock Information
  • Founded
  • ALXO 2015
  • GWH 2011
  • Country
  • ALXO United States
  • GWH United States
  • Employees
  • ALXO N/A
  • GWH N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • ALXO Health Care
  • GWH Miscellaneous
  • Exchange
  • ALXO Nasdaq
  • GWH Nasdaq
  • Market Cap
  • ALXO 28.3M
  • GWH 29.3M
  • IPO Year
  • ALXO 2020
  • GWH N/A
  • Fundamental
  • Price
  • ALXO $0.42
  • GWH $2.25
  • Analyst Decision
  • ALXO Strong Buy
  • GWH Hold
  • Analyst Count
  • ALXO 6
  • GWH 5
  • Target Price
  • ALXO $3.54
  • GWH $2.10
  • AVG Volume (30 Days)
  • ALXO 515.3K
  • GWH 35.4K
  • Earning Date
  • ALXO 05-08-2025
  • GWH 05-16-2025
  • Dividend Yield
  • ALXO N/A
  • GWH N/A
  • EPS Growth
  • ALXO N/A
  • GWH N/A
  • EPS
  • ALXO N/A
  • GWH N/A
  • Revenue
  • ALXO N/A
  • GWH $6,295,000.00
  • Revenue This Year
  • ALXO N/A
  • GWH $204.61
  • Revenue Next Year
  • ALXO N/A
  • GWH $159.83
  • P/E Ratio
  • ALXO N/A
  • GWH N/A
  • Revenue Growth
  • ALXO N/A
  • GWH N/A
  • 52 Week Low
  • ALXO $0.44
  • GWH $1.96
  • 52 Week High
  • ALXO $17.50
  • GWH $14.10
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 31.14
  • GWH 44.22
  • Support Level
  • ALXO $0.49
  • GWH $2.02
  • Resistance Level
  • ALXO $0.55
  • GWH $2.40
  • Average True Range (ATR)
  • ALXO 0.05
  • GWH 0.14
  • MACD
  • ALXO 0.00
  • GWH 0.05
  • Stochastic Oscillator
  • ALXO 4.92
  • GWH 61.54

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: